Prenatal Immune Challenge Disrupts Sensorimotor Gating in Adult Rats: Implications for the Etiopathogenesis of Schizophrenia

Increasing evidence associates schizophrenia with prenatal exposure to infection. Impaired ability to “gate out” sensory and cognitive information is considered to be a central feature of schizophrenia and is manifested, among others, in disrupted prepulse inhibition (PPI) of the acoustic startle reflex. We analyzed the effect of a prenatal immune challenge— peripheral administration of bacterial endotoxin lipopolysaccharide (LPS) to pregnant female rats—upon PPI and immune function in adult offspring. Prenatal LPS treatment disrupted PPI which was reversed by antipsychotics. Serum levels of interleukin-2 and interleukin-6 were increased. In addition, histopathological features in brain areas related with PPI circuitry were observed. These results illustrate the critical influence of prenatal immune events upon adult CNS functioning in association with the putative role of the immune system in the etiopathogenesis of schizophrenia.

[1]  Burkhard Becher,et al.  Brain‐immune connection: Immuno‐regulatory properties of CNS‐resident cells , 2000, Glia.

[2]  M. Geyer,et al.  Dopaminergic stimulation disrupts sensorimotor gating in the rat , 2004, Psychopharmacology.

[3]  C. Flachskamm,et al.  Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. , 1994, Endocrinology.

[4]  C. Dinarello.  Interleukin-1 and the pathogenesis of the acute-phase response. , 1984, The New England journal of medicine.

[5]  J. Merrill,et al.  Cytokine receptors on glial cells , 1994, Glia.

[6]  N. Swerdlow,et al.  Cross‐species Studies of Sensorimotor Gating of the Startle Reflex , 1999, Annals of the New York Academy of Sciences.

[7]  F. Bloom,et al.  Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function 1 Published on the World Wide Web on 24 October 1997. 1 , 1998, Brain Research Reviews.

[8]  D. Weinberger,et al.  Schizophrenia as a developmental disorder of the cerebral cortex , 1998, Current Opinion in Neurobiology.

[9]  P. Falkai,et al.  Evidence for activation of microglia in patients with psychiatric illnesses , 1999, Neuroscience Letters.

[10]  F. Holsboer,et al.  Cellular Localization of Interleukin 6 mRNA and Interleukin 6 Receptor mRNA in Rat Brain , 1993, The European journal of neuroscience.

[11]  Hyung-Cheul Shin,et al.  Interleukin 2 suppresses afferent sensory transmission in the primary somatosensory cortex , 1995, Neuroreport.

[12]  L. Garey,et al.  Increase in HLA‐DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics , 2000, Journal of neuropathology and experimental neurology.

[13]  J. Trojanowski,et al.  Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia , 1996, Acta Neuropathologica.

[14]  P. Dalgalarrondo,et al.  Abnormalities in serum concentrations of interleukin-2, interferon-α and interferon-γ in schizophrenia not detected , 1992, Schizophrenia Research.

[15]  Daniel R Weinberger,et al.  To Model a Psychiatric Disorder in Animals: Schizophrenia As a Reality Test , 2000, Neuropsychopharmacology.

[16]  A. Bruce-Keller.  Microglial–neuronal interactions in synaptic damage and recovery , 1999, Journal of neuroscience research.

[17]  P. Munk-Jørgensen,et al.  Epidemiological Evidence that Maternal Influenza Contributes to the Aetiology of Schizophrenia , 1993, British Journal of Psychiatry.

[18]  J. Borrell,et al.  Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF , 1990, Brain Research.

[19]  J. Bruno,et al.  Sensory gating in rats depleted of dopamine as neonates: potential relevance to findings in schizophrenic patients , 1992, Biological Psychiatry.

[20]  U. Andersson,et al.  Bacterial Toxin‐Induced Cytokine Production Studied at the Single‐Cell Level , 1992, Immunological reviews.

[21]  C. Plata-salamán.  Immunoregulators in the nervous system , 1991, Neuroscience & Biobehavioral Reviews.

[22]  Mark Hallett,et al.  Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results , 1996, Biological Psychiatry.

[23]  R. Depoortère,et al.  Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity , 1997, Psychopharmacology.

[24]  C. Dinarello,et al.  Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. , 1986, Science.

[25]  R. Murray,et al.  Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic , 1991, The Lancet.

[26]  T. Möller,et al.  Neurotoxic consequences of central long-term administration of interleukin-2 in rats , 1997, Neuroscience.

[27]  D. Kirch.  Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. , 1993, Schizophrenia bulletin.

[28]  N. Swerdlow,et al.  Reversal of Isolation Rearing-Induced Deficits in Prepulse Inhibition by Seroquel and Olanzapine , 1998, Biological Psychiatry.

[29]  Y. Kim,et al.  Decreased Interleukin-2 Production in Korean Schizophrenic Patients , 1998, Biological Psychiatry.

[30]  A. Loranger.  Sex difference in age at onset of schizophrenia. , 1984, Archives of general psychiatry.

[31]  Ine,et al.  Effects of Family History and Place and Season of Birth on the Risk of Schizophrenia , 2000 .

[32]  H. Anisman,et al.  Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation , 1998, Brain Research.

[33]  R. Dantzer,et al.  Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.

[34]  N. Swerdlow,et al.  Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. , 1994, Archives of general psychiatry.

[35]  H. Besedovsky,et al.  Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. , 1987, Science.

[36]  D. Rubinow,et al.  The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. , 1987, Annals of internal medicine.

[37]  A. Loranger.  Sex difference in age at onset of schizophrenia , 1984 .

[38]  Jane S. Paulsen,et al.  Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[39]  B. Rabin,et al.  Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness , 1994, Psychiatry Research.

[40]  E. Torrey,et al.  Seasonality of schizophrenic births in the United States. , 1977, Archives of general psychiatry.

[41]  P. Müller-Preuss,et al.  Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  T. Marunouchi,et al.  Induction of Functional Interleukin‐2 Receptor in Mouse Microglia , 1995, Journal of neurochemistry.

[43]  M A Geyer,et al.  Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. , 1998, Schizophrenia bulletin.

[44]  E. Emamian,et al.  Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice , 1999, Molecular Psychiatry.

[45]  Daniel R Weinberger,et al.  On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia , 1996, Neuropsychopharmacology.

[46]  J. Wettstein,et al.  On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia , 1999, Neuropharmacology.

[47]  J. Borrell,et al.  Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids. , 1992, Endocrinology.

[48]  R. Quirion,et al.  Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system , 1989, Brain Research.

[49]  J. P. Schwartz,et al.  Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives , 1998, Journal of neuroscience research.

[50]  J. Reul,et al.  Tumour necrosis factor‐α and interleukin‐2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic–pituitary–adrenocortical axis activity in the rat , 1998, The European journal of neuroscience.

[51]  C. A. Morgan,et al.  Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder , 1996, Psychiatry Research.

[52]  A. Hamm,et al.  Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients , 2000, Biological Psychiatry.

[53]  N. Swerdlow,et al.  A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder , 1993, Biological Psychiatry.

[54]  D. Nance,et al.  Interleukin-2 and -6 induce behavioral-activating effects in mice , 1998, Brain Research.

[55]  M. Geyer,et al.  Prestimulus effects on human startle reflex in normals and schizophrenics. , 1978, Psychophysiology.

[56]  C. Guaza,et al.  Endotoxin administration induced differential neurochemical activation of the rat brain stem nuclei , 1996, Brain Research Bulletin.

[57]  L. Wecker,et al.  Neonatal cytomegalovirus exposure decreases prepulse inhibition in adult rats: Implications for schizophrenia , 1999, Journal of neuroscience research.

[58]  F. Holsboer,et al.  Influence of endotoxin on nocturnal sleep in humans. , 1993, The American journal of physiology.

[59]  W. Banks,et al.  Penetration of interleukin-6 across the murine blood-brain barrier , 1994, Neuroscience Letters.

[60]  W. Banks,et al.  Interleukin-2 does not cross the blood-brain barrier by a saturable transport system , 1994, Brain Research Bulletin.

[61]  K. Akiyama.  Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration , 1999, Schizophrenia Research.

[62]  T. Sharma,et al.  Normalization of information processing deficits in schizophrenia with clozapine. , 1999, The American journal of psychiatry.

[63]  D. Bonett,et al.  Adult schizophrenia following prenatal exposure to an influenza epidemic. , 1988, Archives of general psychiatry.

[64]  H. Hoffman,et al.  Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. , 1980, Psychological review.

[65]  N. Rothwell,et al.  Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.

[66]  Alexander R. Cools,et al.  The effects of an early stressful life event on sensorimotor gating in adult rats , 1998, Schizophrenia Research.